NVOS (Novo Integrated Sciences) FCF Margin %: -20.88% (As of May. 2024)


NVOS Novo Integrated Sciences Inc NVOS
12 GF Score
Price $0.00
View Full Analysis

What is Novo Integrated Sciences FCF Margin %?

Novo Integrated Sciences NVOS 12 FCF Margin % is -20.88% as of May. 2024. GuruFocus rates NVOS with a GF Score™ of 12/100.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Novo Integrated Sciences's Free Cash Flow for the three months ended in May. 2024 was $-0.66 Mil. Novo Integrated Sciences's Revenue for the three months ended in May. 2024 was $3.15 Mil. Therefore, Novo Integrated Sciences's FCF Margin % for the quarter that ended in May. 2024 was -20.88%.

As of today, Novo Integrated Sciences's current FCF Yield % is -6,888.41%.

The historical rank and industry rank for Novo Integrated Sciences's FCF Margin % or its related term are showing as below:

NVOS' s FCF Margin % Range Over the Past 10 Years
Min: -35.16   Med: 0   Max: 0
Current: -35.16


NVOS's FCF Margin % is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 3.34 vs NVOS: -35.16


Novo Integrated Sciences FCF Margin % Related Terms


Novo Integrated Sciences FCF Margin % Historical Data

* Premium members only.

The historical data trend for Novo Integrated Sciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novo Integrated Sciences FCF Margin % Chart

Novo Integrated Sciences Annual Data
Trend Dec14 Dec15 Dec16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9.87 -5.78 -13.77 -51.75 -18.23

Novo Integrated Sciences Quarterly Data
Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -26.06 -6.93 -55.31 -54.05 -20.88

NVOS vs BACK, NHLG, FCHS: FCF Margin % Comparison

For the Medical Care Facilities subindustry, Novo Integrated Sciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novo Integrated Sciences FCF Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Novo Integrated Sciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Novo Integrated Sciences's FCF Margin % falls into.


NVOS
12GF Score
Novo Integrated Sciences Inc NVOS
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Novo Integrated Sciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Novo Integrated Sciences's FCF Margin for the fiscal year that ended in Aug. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Aug. 2023 )/Revenue (A: Aug. 2023 )
=-2.292/12.572
=-18.23 %

Novo Integrated Sciences's FCF Margin for the quarter that ended in May. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: May. 2024 )/Revenue (Q: May. 2024 )
=-0.658/3.152
=-20.88 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -20.88% mean?
Novo Integrated Sciences (NVOS) has a FCF Margin % of -20.88% as of May. 2024. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Novo Integrated Sciences and its competitors.
Is Novo Integrated Sciences' FCF Margin % too high?
Novo Integrated Sciences' current FCF Margin % is -20.88%. Overall, Novo Integrated Sciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Novo Integrated Sciences' FCF Margin % compare to BACK and NHLG?
Novo Integrated Sciences' FCF Margin % of -20.88% can be compared against companies in the Healthcare Providers & Services industry. The industry median FCF Margin % is 3.34. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.34, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Novo Integrated Sciences and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Novo Integrated Sciences's current FCF Margin % is -20.88%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novo Integrated Sciences stock overvalued right now?
Novo Integrated Sciences (NVOS) has a current FCF Margin % of -20.88%. The current FCF Margin % is -20.88%. Novo Integrated Sciences' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Novo Integrated Sciences (NVOS), the current FCF Margin % is -20.88% as of May. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Novo Integrated Sciences Business Description

Address 11120 NE 2nd Street, Suite 100, Bellevue, WA, USA, 98004
Novo Integrated Sciences Inc is a medical care company. It provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, neurological functions, kinesiology, and others. It has two reportable segments: healthcare services and product sales. Healthcare services generate the majority of revenue.
12GF Score

Get the complete analysis for NVOS

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price